Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

279results about "Library member identification" patented technology

High-throughput analysis of n-linked glycosylation site occupancy in proteins and peptides

The present disclosure relates to methods for high-throughput analysis of proteins and peptides employing a set of engineered binders that recognize terminal amino acid residues of peptide analytes. In particular, disclosed herein is the analysis of occupancy of N-linked glycosylation sites in proteins and peptides. The disclosure finds utility at large-scale profiling of N-linked glycosylation sites, as well as monitoring changes in glycosylation patterns associated with numerous disease conditions.
Owner:ENCODIA INC

Methods of engineering transferrin receptor binding polypeptides

Provided herein are polypeptides that bind to a transferrin receptor, methods of generating such polypeptides, and methods of using the polypeptides to target a composition to a transferrin receptor-expressing cell.
Owner:DENALI THERAPEUTICS INC

Compositions and methods for detecting and regulating fibronectin-integrin interaction and signaling

Provided are antibodies that include amino acid sequences of SEQ ID NOs: 2, 4, and 6-12, or amino acid sequences that are about 95% identical thereto, and fragments thereof. Also provided are scFv peptides that include a VH segment having a first amino acid sequence of amino acids 4-113 of any one of SEQ ID NOs: 2 and 8-12, a VL segment having a second amino acid sequence having amino acids 113-237 of SEQ ID NOs. 2 and 8-12, or both; nucleic acids encoding the same; methods for using the same to detect and / or target conformational states of FN in samples; methods for treating diseases and / or disorders and / or for meliorating at least one symptom of consequence of a disease or disorder associated with abnormal expression of a force-induced conformational state of FN in subjects; and methods for screening for compounds having selective binding activities for conformational states of FN.
Owner:GEORGIA TECH RES CORP +1

Spatial transcriptomic library preparation materials and methods

The present disclosure relates generally to methods for improving the preparation of spatial transcriptomic RNA libraries, such as mRNA libraries, by improving in situ capture of RNA transcript information from tissue samples. The spatial transcriptomic library from a tissue sample can be used to determine genetic maps and help diagnose persons having or at risk of having diseases, such as cancer, genetic diseases, autoimmune diseases, and other indications, and improve treatment of subjects.
Owner:ILLUMINA INC

Reagents and methods for analyzing associated nucleic acids

This application relates to reagents and methods for analyzing associated nucleic acids. Specifically, reagents and methods are provided for analyzing nucleic acids (e.g., genomic DNA) of circulating particles (i.e., particles derived from blood). The method includes associating at least two target nucleic acid fragments of the circulating particles to produce a group of at least two associated target nucleic acid fragments. In the method, the target nucleic acid fragments can be associated by techniques such as barcoding, partitioning, ligation, and / or individual sequencing. Sequencing of the group of associated fragments provides a group of informationally associated sequence reads corresponding to the sequences of the fragments from a single particle.
Owner:CS GENETICS

Pre-templated instant partitioning of dna-encoded libraries

This disclosure provides a powerful screening platform that combines pre-templated instant partitions with DNA-encoded library (DEL) technologies to identify target small molecule interactions and analyze their intracellular effects in single cell resolution using methods that require minimal sample preparation and affordable sequencing costs. These methods are well suited for rapidly evaluating drug candidates by simultaneously detecting novel target-binding molecules while screening their transcriptional effects with a single affordable, high throughput workflow.
Owner:FLUENT BIOSCIENCES INC

Methods for standardized sequencing of nucleic acids and uses thereof

To provide a method for determining the quantity of native nucleic acid targets, for providing reproducibility in measurement of nucleic acid copy number in samples, for a NGS method that reduces inter-experimental and inter-laboratory variation in measurement of nucleic acid copy number in samples.SOLUTION: Described is a method comprising measuring a proportional relationship of at least one native target sequencing event of at least one nucleic acid in a sample to the respective competitive internal amplification control (IAC) for that nucleic acid. Also described is a method where the at least one event comprises: an observation, a count and / or a read between the native target and its respective IAC.SELECTED DRAWING: Figure 1
Owner:UNIVERSITY OF TOLEDO

Peptides and combinations thereof for use in immunotherapy for acute myeloid leukemia (AML) and other hematological malignancies

The present invention relates to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. Specifically, the present invention relates to the immunotherapy of cancer, particularly hematological tumors such as acute myeloid leukemia (AML). Furthermore, the present invention relates to tumor-associated T cell peptide epitopes that can be used, for example, as active pharmaceutical ingredients in vaccine compositions to stimulate anti-tumor immune responses or that can stimulate ex vivo T cells for transfer into patients. Peptides bound to major histocompatibility complex (MHC) molecules, and even the peptides themselves, may be targets for antibodies, soluble T cell receptors, and other binding molecules.
Owner:EBERHARD KARLS UNIV TUBINGEN MEDIZINISCHE FAKULTAT

Systems and methods for nucleic acid preparation

The present disclosure provides methods and systems for nucleic acid processing. A method for preparing a sequencing set may include providing a template nucleic acid and amplifying the template nucleic acid to provide a complementary nucleic acid. Next, the complementary nucleic acid may be fragmented and barcoded to produce a first set of barcoded fragments comprising a plurality of first barcoded fragments. Next, the plurality of first barcoded fragments may be fragmented to yield a second set of barcoded fragments comprising a plurality of second barcoded fragments.
Owner:10X GENOMICS INC

Method for non-invasive prenatal screening for aneuploidy

The present disclosure provides methods for non-invasive prenatal screening (NIPS) of fetal aneuploidies. The present methods are based on analyzing cell-free fetal DNA (cff DNA) found in a pregnant woman's circulation through the next generation sequencing (NGS) technology. Particularly, the present methods analyze the relative abundance of different fetal genomic fragments present in the maternal sample, where the fragments can be aligned to particular chromosomal locations of the fetal genome. The relative abundance information is indicative as to whether a particular chromosome is overrepresented or underrepresented in a fetal genome as compared to normal individuals, and thus can be used to detect fetal aneuploidy. Additionally, methods for increasing the positive predictive values (PPV) of NIPS by excluding false-positive detections are also provided.
Owner:QUEST DIAGNOSTICS INVESTMENTS INC

DNA library sequence for increasing number of chip probes and application thereof

A DNA library sequence for increasing the number of chip probes and an application thereof. The DNA library sequence comprises two or more position information labeling sequences and three or more fixed sequences, wherein the position information labeling sequences and the fixed sequences are arranged at intervals. The DNA library sequence increases the number of probes of a chip used for spatiotemporal omics, and then a capture number of transcript genes is increased. The present invention has a very high application prospect.
Owner:STOMICS TECH CO LTD

Sequential encoding methods and related kits

The present disclosure relates to methods and kits for analyzing a macromolecule. In some embodiments, the present disclosure relates to macromolecule analysis methods which employ barcoding and nucleic acid encoding of molecular recognition events. Also provided herein is a method and related kits for transferring information using a plurality of enzymes, including for performing a ligation, extension, and cleavage reaction with nucleic acid molecules associated with the macromolecule for analysis. In some embodiments, the macromolecule for analysis comprises a peptide, a polypeptide, or a protein.
Owner:ENCODIA INC

Biochip and methods of use and preparation thereof

A biochip (100) and methods of use and preparation thereof. The biochip (100) comprises: a solid support having a front side (101) and a back side (102); a plurality of feature sites (110) arranged in an array and a plurality of biomolecule sequences attached to the plurality of feature sites (110) are formed on the front surface (101), each biomolecule sequence at least comprises a positioning sequence, and the positioning sequence comprises information indicating the spatial position of the biomolecule sequence on the biochip (100). And the back surface (102) is provided with at least one of a first mark (120) which can be recognized by human eyes and a second mark (130) which can be recognized by an instrument.
Owner:SHENZHEN HUADA SANJIAN QIFA TECHNOLOGY CO LTD

Directed evolution of engineered virus-like particles (EVLPS)

The present disclosure provides methods, compositions, and systems for evolving virus-like particles (VLPs) having one or more desired properties such as increased production levels, increased cargo packaging efficiency, and / or increased transduction of particular target cell types of interest. The present disclosure also provides libraries for use in such methods, and methods for producing the libraries. Group specific antigen (gag) proteins comprising nucleocapsid protein variants evolved using the methods described herein are also provided herein. The present disclosure also provides VLPs comprising such gag proteins comprising nucleocapsid protein variants. Polynucleotides, vectors, cells, and kits useful for performing the methods described herein are also provided.
Owner:THE BROAD INST INC +1

Approaches to designing and performing compressed biological experiments and systems for implementing the same

Introduced here are approaches to compressing members of libraries into pools for screening. These members could be biological targets to be screened against a drug, or these members could be drugs to be screened against a biological target. Regardless of their nature, the members can be compressed into pools in accordance with an informed pooling operation. As part of the informed pooling operation, the members can be divided among the pools such that (i) each member is in a subset of the pools, (ii) each pool includes at least three members, and (iii) no two members are in an identical subset of the pools.
Owner:EXVIVO LABS INC

Highly multiplexed phylogenetic imaging of microbial communities

Micron scale biogeography is a major driver of physiology and ecology of complex microbial biofilm communities, which remains elusive largely due to the lack of tools for spatially resolved phylogenetic mapping. This disclosure provides methods, computer-readable storage devices and kits that allow highly multiplexed and spatially resolved imaging of microbial community spatial organization. The disclosure provides a highly-multiplexed approach to resolve the spatial structure of complex microbial community at high taxonomic resolution.
Owner:CORNELL UNIVERSITY

Directed evolution of engineered virus-like particles (EVLPS)

The present disclosure provides methods, compositions, and systems for evolving virus-like particles (VLPs) having one or more desired properties such as increased production levels, increased cargo packaging efficiency, and / or increased transduction of particular target cell types of interest. The present disclosure also provides libraries for use in such methods, and methods for producing the libraries. Group specific antigen (gag) proteins comprising nucleocapsid protein variants evolved using the methods described herein are also provided herein. The present disclosure also provides VLPs comprising such gag proteins comprising nucleocapsid protein variants. Polynucleotides, vectors, cells, and kits useful for performing the methods described herein are also provided.
Owner:THE BROAD INST INC +1

Neoantigen Identification Using Pan-Allelic Models

A method for identifying neoantigens that may be presented by MHC alleles on the surface of tumor cells of a subject. The peptide sequence of the tumor neoantigen and the peptide sequence of the MHC allele are obtained by sequencing the tumor cells of the subject. The peptide sequence of the tumor neoantigen and the peptide sequence of the MHC allele are input into a machine learning presentation model to generate presentation probabilities of the tumor neoantigen, each presentation probability representing the probability that the neoantigen is presented by at least one of the MHC alleles on the surface of the tumor cells of the subject. A subset of the neoantigens is selected based on the presentation probabilities.
Owner:SEATTLE PROJECT CORP

Spatial transcriptomics library preparation materials and methods

The present disclosure relates, in general, to methods for improving preparation of a spatial transcriptomics RNA, library, for example a mRNA library, by improving capture of RNA transcript information from a tissue sample in situ. The spatial transcriptomics library from a tissue sample is useful to determine a genetic profile and help diagnose a person who has or is at risk of having a disease, such as cancer, genetic disease, autoimmune disease, and other indications, and improve treatment of the subject.
Owner:ILLUMINA INC

Reversibly reactive affinity selection mass spectrometry and uses thereof

PCT designated stage expiredWO2025111511A9Peptide librariesLibrary screeningHpv16 e6Mass Spectrometry-Mass Spectrometry
This disclosure relates to reversible affinity selection methods useful for the isolation and enrichment of covalent peptide inhibitors directly from large synthetic peptide libraries. Also disclosed herein are synthetic peptides for targeting HPV16 E6 and peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 protein.
Owner:CALICO LIFE SCI LLC +1

Array and method for detecting spatial information of nucleic acids

The present application provides a nucleic acid array for detecting spatial information of nucleic acids in a sample, a method for detecting spatial information of nucleic acids in a sample on the basis of the array, and a method for producing the nucleic acid array.
Owner:SHENZHEN HUADA GENE INST +1

Array for detecting spatial information of nucleic acid and detection method

The invention relates to the field of biological molecule space detection. The invention provides an array for detecting nucleic acid spatial information and a detection method. Specifically, in order to realize single cell even subcellular level and high throughput detection of spatial information (e.g., localization, distribution and / or expression of nucleic acid) of biomolecules, the invention provides a nucleic acid array for detecting spatial information of nucleic acid in a sample. The nucleic acid array is obtained by providing a carrier sequence containing a positioning sequence and a first fixed sequence in the direction from 5'to 3 ', and when the nucleic acid array is applied to nucleic acid space information detection, high-precision subcellular positioning and high-throughput tissue positioning can be achieved at the same time.
Owner:SHENZHEN HUADA SANJIAN QIFA TECHNOLOGY CO LTD +1